Characterisation and mRNA expression analysis of the bronchial hyperresponsiveness susceptibility gene protocadherin-1 in asthma patients Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009
Assessment of cytokine mRNA expression in patients with COPD exacerbations Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
DPP10 protein expression is associated with the pathogenesis of asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 231s Year: 2005
Gene expression in bronchial biopsies from subjects with persistent asthma and asthma in remission Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017
Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021
MMP-9 gene variants increase the risk for non-atopic asthma in children Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010
The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012
Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007
Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020
Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Relationship between asthma control and quality of life in different levels of asthma severity Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases Year: 2010
The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2 Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Significance of microRNAs in allergic asthma patients. Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017
The bronchial expression of vanin in moderate to severe asthma Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019
The influence of different rehabilitation methods on level of anxiety in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 454s Year: 2002
Relationship of lung function to asthma severity in asthmatic families Source: Eur Respir J 2005; 26: Suppl. 49, 397s Year: 2005
Airway gene expression identifies subtypes of Type 2 inflammation in severe asthma Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
The expression of selected biomarkers at the systemic and local level in patients with COPD Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020
Asthma in combination with rhinitis and eczema is associated with higher levels of type-2 inflammation and symptom burden Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021